Obatala Sciences, Inc. is a biotechnology company that provides organ-on-a-chip solutions for research, with its office located in New Orleans, Louisiana.
Subscribe to see Obatala Sciences, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Obatala Sciences, Inc. is a healthcare company headquartered in United States. It has raised at least $3.5M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $3M in October 2022. Xcout tracks 8 named people at Obatala Sciences, Inc., including Cecilia Sanchez (Chief Scientific Officer & VP of R&D).
2 more named people on record for Obatala Sciences, Inc., with roles, board committees and tenure — see the full roster →
At least $3.5M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $3M | 5 named | |
| SEC Form D filing | $535,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Obatala Sciences, Inc.'s closest competitors — see the full list of competitors and alternatives →
Fluicell develops precision-engineered biological tissues and single-cell bioprinting technologies for regenerative medicine and drug screening. Using its proprietary platforms, including Nexocyte and Biopixlar, the company creates transplantable tissues to target diseases such as type 1 diabetes and provides advanced tools and screening models for pharmaceutical and academic partners.
Organoid Therapeutics, Inc. is a biotechnology contract research organization (CRO) that provides human brain tissue models, neuronal phenotyping, drug screening, and machine learning-based analytical services. The company serves pharmaceutical, biotech, and academic researchers by conducting pre-clinical research and translational studies to evaluate drug efficacy, neurotoxicity, and neurological disease models.
Jurata Thin Film is a biotechnology firm specializing in innovative thin film technology designed to revolutionize biological sample storage and stabilization. The company maintains corporate operations and research facilities in Chapel Hill, North Carolina, and Houston, Texas.
iOrganBio is a biotechnology company founded in 2024 that develops AI-powered platforms for the precision engineering and manufacturing of human cells and organoids. The company's CellForge platform aims to create reproducible human cell models for research applications, including cardiac disease studies and biological simulation.
Hubrecht Organoid Technology (HUB) develops patented patient-derived organoid technology from healthy and diseased tissues to predict patient responses to treatments. The company functions as a contract research organization (CRO), offering drug discovery services, custom model and assay development, clinical trials in a dish, and licensing programs for pharmaceutical and research applications.
Biodimension Technology Private Limited is a biotechnology company headquartered in Bangalore, Karnataka, India. The firm specializes in developing and manufacturing biofabricated human tissue models for research and testing applications.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.